InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

10x Genomics, Inc.

TXG Clue Score54
United States Fiscal year ends December CIK 0001770787 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Serge Saxonov
5 Jan 2026
Chief Executive Officer
Exercised, kept
50,000
$1.20
$60.00K
Serge Saxonov
4 Mar 2025
Chief Executive Officer
Exercised, kept
50,000
$1.20
$60.00K
Serge Saxonov
23 Dec 2024
Chief Executive Officer
Exercised, kept
12,000
$1.20
$14.40K
Benjamin J. Hindson
28 Dec 2023
See Remarks
Exercised, kept
8,334
$11.48
$95.67K
Serge Saxonov
27 Dec 2023
Chief Executive Officer
Exercised, kept
14,935
$1.20
$17.92K
Benjamin J. Hindson
14 Dec 2022
See Remarks
Exercised, kept
34,266
$5.04
$172.70K
Serge Saxonov
12 Dec 2022
Chief Executive Officer
Exercised, kept
3,000
$1.20
$3.60K
Sridhar Kosaraju
14 Sep 2022
Director
Exercised, kept
10,000
$11.48
$114.80K
Serge Saxonov
12 Sep 2022
Chief Executive Officer
Exercised, kept
11,500
$1.20
$13.80K
Sridhar Kosaraju
16 May 2022
Director
Exercised, kept
15,000
$11.48
$172.20K
Benjamin J. Hindson
28 Dec 2021
See Remarks
Exercised, kept
59,968
$1.20
$71.96K
Benjamin J. Hindson
28 Dec 2021
See Remarks
Exercised, kept
53,952
$1.07
$57.73K
Serge Saxonov
28 Dec 2021
Chief Executive Officer
Exercised, kept
56,363
$1.20
$67.64K
Bradford Crutchfield
21 Dec 2021
Chief Commercial Officer
Exercised, kept
49,910
$5.04
$251.55K
Bradford Crutchfield
21 Dec 2021
Chief Commercial Officer
Exercised, kept
4,688
$1.20
$5.63K
Showing 250 of 973 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 386
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 59
Sales straight out of an exercise 546
Sales at will 331
Transactions with no price 0
Shares from compensation/vesting 60,548,376
Sales filed before the plan box existed 273
History held since 12 Sep 2019